Netilmicin is a newer aminoglycoside with pharmacological properties similar to those of gentamicin, tobramycin, and sisomicin (8, 11, 12) . It reportedly has a decreased potential for oto-and nephrotoxicity in humans (6) and thus may be used in somewhat elevated doses, achieving levels in blood higher than those obtained with gentamicin, tobramycin, or sisomicin. Consequently, for in vitro susceptibility testing, tentative MIC breakpoints separating susceptible and resistant categories should be between those used for kanamycin-like aminoglycosides and those used for gentamicin or tobramycin. In the testing of aminoglycosides, the tradition of using only twofold dilutions causes some difficulty; closer dilution intervals seem more appropriate for this group of drugs. We have recently recommended that for gentamicin, tobramycin, and sisomicin, the MIC breakpoint for the susceptible category should be .6.0 rather than c4.0 p.g/ml (3, 4 
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performed standard disk diffusion tests (9) with 30-,ug netilmicin disks. Microdilution tests were performed according to the National Committee for Clinical Laboratory Standards (10). Each laboratory generated two MICs for each strain tested. Thus, six MICs were accumulated for each strain, and geometric mean MICs (log2) were calculated and plotted against the arithmetic mean of two zone diameters (millimeters). Precision of data generated in this manner was very acceptable, as documented in reports of other aminoglycosides, cephalosporins, and semisynthetic penicillins (1-3). (Fig. 1B) . Six strains gave MICs of .1 ,ug/ml (not included in Fig. 1) ; they produced zones 24 to 28 mm in diameter. Six other strains provided MICs of >32 ,ug/ml; their zone sizes are included in Fig. 1 but were not used for regression analysis. If even log2 dilution intervals had been tested (Fig. 1B) (Fig. 1B) . A 15-mm zone correlated with an MIC of just below 16 ,ug/ml (15.6 ,ug/ml).
By plotting intermediate MICs obtained by close-interval dilution tests, the correlation coefficient was improved (0.82 versus 0.74). Examination of these data (Fig. 1A) revealed that strains with zones in the 15-to 16-mm range were actually inhibited by 14 ,ug/ml or less and that most required MICs of .12 ,ug/ml, whereas the majority of strains with zones of <15 mm required MICs of >12 ,ug/ml. These facts suggest that strains with zones of .15 mm might be considered susceptible to 12 ,ug or less of netilmicin per ml.
Strains with known resistance mechanisms were next examined to clearly define the susceptibility breakpoint. Table 1 shows the P. aeruginosa isolates that have been studied to date. They can be separated into resistant and susceptible populations according to the type of aminoglycoside-modifying enzyme that was identified. The distribution of zone sizes that were recorded is shown in Fig. 2 These recommendations are based on our studies with P. aeruginosa. Since very few members of the family Enterobacteriaceae produce zones in the 15-to 16-mm range, the above modified zone size breakpoints might be applied also to tests with the enteric bacilli and other species. However, limited data with aminoglycoside-resistant enteric bacilli suggest that a susceptible breakpoint of .17 mm might be more appropriate for 30-p,g netilmicin disks when testing species other than P. aeruginosa (Miller, personal communication). Until appropriate studies have been reported indicating that the same set of zone size breakpoints may be applied to all species, we recommend breakpoints of <12 and .15 mm for tests with P. aeruginosa and <13 and .17 mm for all other gram-negative bacilli.
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